362 related articles for article (PubMed ID: 28179585)
41. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
Liu Y; Hock JM; Van Beneden RJ; Li X
Mol Carcinog; 2014 May; 53(5):380-91. PubMed ID: 23255470
[TBL] [Abstract][Full Text] [Related]
42. Oxidative stress, DNA methylation and carcinogenesis.
Franco R; Schoneveld O; Georgakilas AG; Panayiotidis MI
Cancer Lett; 2008 Jul; 266(1):6-11. PubMed ID: 18372104
[TBL] [Abstract][Full Text] [Related]
43. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water.
Andrew AS; Karagas MR; Hamilton JW
Int J Cancer; 2003 Apr; 104(3):263-8. PubMed ID: 12569548
[TBL] [Abstract][Full Text] [Related]
44. Arsenic and UVR co-exposure results in unique gene expression profile identifying key co-carcinogenic mechanisms.
Speer RM; Yu H; Zhou X; Nandi S; Alexandrov L; Guo Y; Hudson LG; Liu KJ
Toxicol Appl Pharmacol; 2024 Jan; 482():116773. PubMed ID: 38036231
[TBL] [Abstract][Full Text] [Related]
45. Arsenic carcinogenesis in the skin.
Yu HS; Liao WT; Chai CY
J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
[TBL] [Abstract][Full Text] [Related]
46. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
47. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
Wynter CV
Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
[TBL] [Abstract][Full Text] [Related]
48. Non-coding RNAs, epigenetics and complexity.
Costa FF
Gene; 2008 Feb; 410(1):9-17. PubMed ID: 18226475
[TBL] [Abstract][Full Text] [Related]
49. Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis.
Latimer JJ; Majekwana VJ; Pabón-Padín YR; Pimpley MR; Grant SG
Photochem Photobiol; 2015; 91(2):493-500. PubMed ID: 25393451
[TBL] [Abstract][Full Text] [Related]
50. Environmental factors and genetic susceptibility promote urinary bladder cancer.
Volanis D; Kadiyska T; Galanis A; Delakas D; Logotheti S; Zoumpourlis V
Toxicol Lett; 2010 Mar; 193(2):131-7. PubMed ID: 20051252
[TBL] [Abstract][Full Text] [Related]
51. Epigenetics of colorectal cancer.
Yan W; Guo M
Methods Mol Biol; 2015; 1238():405-24. PubMed ID: 25421673
[TBL] [Abstract][Full Text] [Related]
52. Long-term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16(INK4a) and down-regulates its expression in the liver of mice.
Suzuki T; Nohara K
J Appl Toxicol; 2013 Sep; 33(9):951-8. PubMed ID: 22733434
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.
Li Y; Zhang Y; Li S; Lu J; Chen J; Wang Y; Li Y; Xu J; Li X
Sci Rep; 2015 Mar; 5():8790. PubMed ID: 25739977
[TBL] [Abstract][Full Text] [Related]
54. Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects.
Bhattacharjee P; Das N; Chatterjee D; Banerjee A; Das JK; Basu S; Banerjee S; Majumder P; Goswami P; Giri AK
Mutat Res; 2013 Jul; 755(1):1-5. PubMed ID: 23644288
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
Kitchin KT
Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
[TBL] [Abstract][Full Text] [Related]
56. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan.
Chen CJ; Hsu LI; Wang CH; Shih WL; Hsu YH; Tseng MP; Lin YC; Chou WL; Chen CY; Lee CY; Wang LH; Cheng YC; Chen CL; Chen SY; Wang YH; Hsueh YM; Chiou HY; Wu MM
Toxicol Appl Pharmacol; 2005 Aug; 206(2):198-206. PubMed ID: 15967209
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects.
Banerjee N; Paul S; Sau TJ; Das JK; Bandyopadhyay A; Banerjee S; Giri AK
Toxicol Sci; 2013 Oct; 135(2):300-8. PubMed ID: 23872714
[TBL] [Abstract][Full Text] [Related]
58. Epigenetics and cancer.
Kanwal R; Gupta S
J Appl Physiol (1985); 2010 Aug; 109(2):598-605. PubMed ID: 20203073
[TBL] [Abstract][Full Text] [Related]
59. [Epigenetics of prostate cancer].
Yi XM; Zhou WQ
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):635-41. PubMed ID: 20873600
[TBL] [Abstract][Full Text] [Related]
60. RNA-directed epigenomic reprogramming: an emerging principle of a more targeted cancer therapy?
Moskalev EA; Schubert M; Hoheisel JD
Genes Chromosomes Cancer; 2012 Feb; 51(2):105-10. PubMed ID: 22045689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
